Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,853
Closed -$584K 366
2026
Q1
$584K Buy
+4,853
New +$560K 0.29% 118
2025
Q4
Sell
-58,095
Closed -$4.88M 560
2025
Q3
$4.88M Buy
+58,095
New +$4.79M 1% 1
2025
Q2
Sell
-2,931
Closed -$263K 548
2025
Q1
$263K Buy
+2,931
New +$274K 0.13% 247
2024
Q3
Sell
-1,719
Closed -$213K 366
2024
Q2
$213K Sell
1,719
-12,518
-88% -$1.61M 0.16% 208
2024
Q1
$1.88M Buy
+14,237
New +$1.75M 1.08% 18

Other funds holding MRK

iSAM Funds (UK)'s MRK Position: Q2 2026 in Review

iSAM Funds (UK) sold out of Merck (MRK) in Q2 2026, closing a stake of 4,853 shares — an estimated $584K sold.

iSAM Funds (UK) first reported a position in MRK in Q1 2024 and held it in 5 quarters. The position peaked at $4.88M in Q3 2025. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • iSAM Funds (UK) reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • iSAM Funds (UK) sold 4,853 Merck shares in Q2 2026, an estimated $584K.
  • iSAM Funds (UK) first reported a position in Merck in Q1 2024 and held it in 5 quarters.
  • iSAM Funds (UK)'s Merck position peaked at $4.88M in Q3 2025.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on iSAM Funds (UK)'s 13F filing for Q2 2026, filed 12 Aug 2026.